Trials / Completed
CompletedNCT04555291
Analgesic Effect of the QLB-3 for Patients Undergoing a Total Hip Surgery
Analgesic Efficiency of the Type 3 Quadratum Lumborum Block in Patients Undergoing Total Hip Arthroplasty : a Randomized Double Blinded Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Total hip arthroplasty (THA) is one of the main elective orthopedic surgery. Recent studies have proven that patients undergoing an elective THA who are part of a fast track surgery program including an opioid free anesthesia (OFA) presented a decrease of mortality and a reduced in-hospital length of stay. Based on the anatomical knowledges, the Quadratus Lumborum Block seems to be an interesting locoregional technique for patients undergoing THA. So far, there is no recommanded locoregional aesthesia in this indication. The investigators hypothezised that QLB would give an efficient analgesia in the 24h following a THA. Therefor, the study performed a prospective, randomized, double blind trial in the Nice Universitary hospital of Pasteur 2 and in Arnault Tzanck Institute among all patients who underwent THA, comparing a QLB using ropivacaïne 2mg/ml 20ml vs isotonic saline solution 20 ml.The main end-point is the decrease opiod consumption in the 24h following THA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine injection | Realization of the quadratum lumborum block type 3, ultrasounds' guided by the injection of 20 ml of ropivacaïne 2 mg/ml |
| OTHER | NACL | Realization of the quadratum lumborum block type 3, ultrasounds' guided by the injection of 20 ml of NACL |
Timeline
- Start date
- 2022-01-05
- Primary completion
- 2023-10-06
- Completion
- 2024-10-10
- First posted
- 2020-09-18
- Last updated
- 2026-03-24
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04555291. Inclusion in this directory is not an endorsement.